{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:39Z","timestamp":1786119459701,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/jcp.0b013e3181d2ef42","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T01:48:34Z","timestamp":1267753714000},"page":"116-125","source":"Crossref","is-referenced-by-count":33,"title":["MRP1 Polymorphisms Associated With Citalopram Response in Patients With Major Depression"],"prefix":"10.1097","volume":"30","author":[{"given":"Sung Hee","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhee-Hun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung-Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Myun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.C.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Goo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 16","key":"R1-4-20210128","first-page":"18","article-title":"Clinical features of treatment-resistant depression.","volume":"62","author":"Kornstein","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.v68n0713","article-title":"Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.","volume":"68","author":"Souery","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R3-4-20210128","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/sj.clpt.6100358","article-title":"Metabolism of antidepressant and neuroleptic drugs by cytochrome p450s: clinical and interethnic aspects.","volume":"82","author":"Bertilsson","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00228-004-0766-8","article-title":"Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.","volume":"60","author":"Grasmader","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00007691-200404000-00017","article-title":"Clinical aspects of the MDR1 (ABCB1) gene polymorphism.","volume":"26","author":"Eichelbaum","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pnpbp.2007.09.003","article-title":"ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.","volume":"32","author":"Kato","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.pharmtox.41.1.569","article-title":"Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.","volume":"53","author":"Lee","year":"2001","journal-title":"Pharmacol Rev"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.","volume":"258","author":"Cole","year":"1992","journal-title":"Science"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/01.fpc.0000167333.38528.ec","article-title":"Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters.","volume":"15","author":"Conseil","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"R10-4-20210128","first-page":"335","article-title":"Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress.","volume":"6","author":"Adachi","year":"2007","journal-title":"J Exp Ther Oncol"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.addr.2004.07.009","article-title":"Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.","volume":"56","author":"de Lange","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.4049\/jimmunol.176.9.5191","article-title":"Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation.","volume":"176","author":"van de Ven","year":"2006","journal-title":"J Immunol"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10555-007-9041-7","article-title":"A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1.","volume":"26","author":"Chang","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tips.2006.06.008","article-title":"Transport of glutathione and glutathione conjugates by MRP1.","volume":"27","author":"Cole","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eplepsyres.2005.11.011","article-title":"Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.","volume":"68","author":"Kubota","year":"2006","journal-title":"Epilepsy Res"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2005.11.011","article-title":"Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier.","volume":"138","author":"Soontornmalai","year":"2006","journal-title":"Neuroscience"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1074\/jbc.M310711200","article-title":"Molecular modeling correctly predicts the functional importance of Phe594 in transmembrane helix 11 of the multidrug resistance protein, MRP1 (ABCC1).","volume":"279","author":"Campbell","year":"2004","journal-title":"J Biol Chem"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1074\/jbc.M311435200","article-title":"Identification of proline residues in the core cytoplasmic and transmembrane regions of multidrug resistance protein 1 (MRP1\/ABCC1) important for transport function, substrate specificity, and nucleotide interactions.","volume":"279","author":"Koike","year":"2004","journal-title":"J Biol Chem"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"38871","DOI":"10.1074\/jbc.M403832200","article-title":"Mutational analysis of ionizable residues proximal to the cytoplasmic interface of membrane spanning domain 3 of the multidrug resistance protein, MRP1 (ABCC1): glutamate 1204 is important for both the expression and catalytic activity of the transporter.","volume":"279","author":"Situ","year":"2004","journal-title":"J Biol Chem"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00008571-200206000-00008","article-title":"A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance.","volume":"12","author":"Conrad","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-1781(99)00082-7","article-title":"The citalopram challenge test in patients with major depression and in healthy controls.","volume":"88","author":"Kapitany","year":"1999","journal-title":"Psychiatry Res"},{"issue":"suppl 1","key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00004850-199603001-00002","article-title":"Pharmacology and pharmacokinetics of citalopram and other SSRIs.","volume":"11","author":"Baumann","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(99)01461-4","article-title":"Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium.","volume":"831","author":"Rochat","year":"1999","journal-title":"Brain Res"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2007.11.017","article-title":"Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.","volume":"57","author":"Uhr","year":"2008","journal-title":"Neuron"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1152\/physrev.00035.2005","article-title":"Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.","volume":"86","author":"Deeley","year":"2006","journal-title":"Physiol Rev"},{"key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O","article-title":"Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group.","volume":"11","author":"Antonarakis","year":"1998","journal-title":"Hum Mutat"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps.","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"R28-4-20210128","first-page":"5130","article-title":"Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione.","volume":"58","author":"Loe","year":"1998","journal-title":"Cancer Res"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"research0034.1","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.1073\/pnas.0401799101","article-title":"Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure.","volume":"101","author":"Mathews","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/nar\/gkj112","article-title":"miRBase: microRNA sequences, targets and gene nomenclature.","volume":"34","author":"Griffiths-Jones","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"GPower 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/sj.bjp.0702360","article-title":"ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.","volume":"126","author":"Renes","year":"1999","journal-title":"Br J Pharmacol"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-3956(03)00022-0","article-title":"abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice.","volume":"37","author":"Uhr","year":"2003","journal-title":"J Psychiatr Res"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.jcp.0000125680.89843.a6","article-title":"Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.","volume":"24","author":"Nikisch","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R36-4-20210128","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pnpbp.2007.09.003","article-title":"ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.","volume":"32","author":"Kato","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.seizure.2007.03.011","article-title":"Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia.","volume":"16","author":"Ak","year":"2007","journal-title":"Seizure"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainres.2004.06.034","article-title":"Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes.","volume":"1021","author":"Mercier","year":"2004","journal-title":"Brain Res"},{"key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.2042-7158.1996.tb05889.x","article-title":"The tricyclic antidepressants clomipramine and citalopram induce apoptosis in cultured human lymphocytes.","volume":"48","author":"Xia","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0006-2952(99)00009-X","article-title":"Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and Bcl-X(L).","volume":"57","author":"Xia","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"R41-4-20210128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2164-7-111","article-title":"Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region.","volume":"7","author":"Wang","year":"2006","journal-title":"BMC Genomics"},{"key":"R42-4-20210128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00228-003-0625-z","article-title":"Frequency of MRP1 genetic polymorphisms and their functional significance in Caucasians: detection of a novel mutation G816A in the human MRP1 gene.","volume":"59","author":"Oselin","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"R43-4-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2133\/dmpk.22.48","article-title":"Genetic variations and haplotype structures of the ABC transporter gene ABCC1 in a Japanese population.","volume":"22","author":"Fukushima-Uesaka","year":"2007","journal-title":"Drug Metab Pharmacokinet"},{"key":"R44-4-20210128","doi-asserted-by":"crossref","first-page":"reviews0004.1","DOI":"10.1186\/gb-2002-3-3-reviews0004","article-title":"Untranslated regions of mRNAs.","volume":"3","author":"Mignone","year":"2002","journal-title":"Genome Biol"},{"key":"R45-4-20210128","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2217\/14622416.8.12.1625","article-title":"Pharmacogenomics of microRNA: a miRSNP towards individualized therapy.","volume":"8","author":"Bertino","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R46-4-20210128","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrm1644","article-title":"MicroRNA biogenesis: coordinated cropping and dicing.","volume":"6","author":"Kim","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R47-4-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tig.2006.01.003","article-title":"Genomics of microRNA.","volume":"22","author":"Kim","year":"2006","journal-title":"Trends Genet"},{"key":"R48-4-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nsmb1226","article-title":"Potent effect of target structure on microRNA function.","volume":"14","author":"Long","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"R49-4-20210128","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1073\/pnas.0706217104","article-title":"A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.","volume":"104","author":"Mishra","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R50-4-20210128","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STARD report.","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R51-4-20210128","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2217\/14622416.9.7.935","article-title":"Pharmacogenomics with antidepressants in the STARD study.","volume":"9","author":"Lin","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R52-4-20210128","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/FPC.0b013e32832e4bcd","article-title":"Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.","volume":"19","author":"Laje","year":"2009","journal-title":"Pharmacogenet Genomics"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201004000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:20:53Z","timestamp":1786040453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201004000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181d2ef42","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}